Stephen Lutoti

Stephen Lutoti

Auto-generated profile, based on publicly available information

Stephen Lutoti

Department of Pharmacy, Makerere University, Kampala, Uganda

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
SLStephen Lutoti
Stephen Lutoti
BKBruhan Kaggwa
Bruhan Kaggwa
PKPakoyo Fadhiru Kamba
Pakoyo Fadhiru Kamba
JMJackson Mukonzo
Jackson Mukonzo
CSCrispin Duncan Sesaazi
Crispin Duncan Sesaazi
EKEsther Katuura
Esther Katuura
Purpose: The study aimed to document the existing knowledge and practices related to breast cancer recognition and treatment using medicinal plants by traditional health practitioners in Central Uganda. Methods: This cross-sectional exploratory survey, conducted between February and August 2020, applied a mixed methods research approach. A semi-structured questionnaire was administered to 119 traditional health practitioners (THPs) in Kampala, Wakiso and Mukono. Content analysis of qualitative data was done. Quantitative ethnobotanical survey indices, namely user reports (Nur), percentage of respondents with knowledge (PRK), informant consensus factor (Fic), fidelity level (FL), preference ranks (PR) and direct matrix ranking (DMR) were determined. Results: Most THPs recognized breast cancer by breast swelling (n=74, 62.2%) and breast pain (n=29, 24.4%). They cited 30 plants from 30 genera in 23 families (Fic 0.75 on breast cancer). Asteraceae, Apocynaceae, Euphorbiaceae, Fabaceae, Lamiaceae and Rutaceae were the predominant families. The ten most cited plants were Annona muricata L. (Nur=24), Rhoicissus tridentata (L.f.) Wild & R.B.Drumm (Nur =19), Erythrococca bongensis Pax (Nur=11), Ficus sp. (Nur=10), Cannabis sativa L. (Nur=8), Ipomoea wightii (Wall.) Choisy (Nur=7), Erythrina abyssinica DC. (Nur=5), Leucas martinicensis (Jacq.) R.Br. (Nur=4), Abelmoschus esculentus (L.) Moench (Nur=4) and Zanthoxylum chalybeum Engl. (Nur=3). Annona muricata L. was highly preferred by THPs (PR 1), Ficus sp. had highest fidelity level (FL=77%) and Zanthoxylum chalybeum Engl. ranked as the highest multipurpose plant (DMR 1). Herbs (n=14, 47%) were the most commonly used life forms besides trees (n=11, 37%) and shrubs (n=5, 16%). THPs mostly used leaves (46%), prepared decoctions (82%) and applied residues on the breast. Conclusion: THPs in Central Uganda recognized breast cancer by symptoms. Medicinal plants applied in its folk treatment have been documented and the claims of cure by THPs merit further investigation.

13 April 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
BKBruhan Kaggwa
Bruhan Kaggwa
HKHenry Kyeyune
Henry Kyeyune
EMEdson Ireeta Munanura
Edson Ireeta Munanura
Godwin AnywarGodwin Anywar
Godwin Anywar
SLStephen Lutoti
Stephen Lutoti
POPatrick Engeu Ogwang
Patrick Engeu Ogwang
Introduction. The Uganda National Drug Authority requires phytochemical screening, freedom from microbial contamination, and evidence of safety and efficacy of the constituent plants to register herbal products. Since Uganda has no pharmacopeia, safety, efficacy, and plant processing information are not readily available. We documented the plant materials used to manufacture products in Uganda and established evidence of their safety and efficacy and availability of monographs. Methods. The NDA register of herbal products was reviewed, and a product list was extracted. The herbal products were purchased from local pharmacies, and their labels were studied to identify plant ingredients and drug use. Literature was reviewed to document evidence of the safety and efficacy of the plant materials concerning manufacturers claims. Also, the WHO and available African Pharmacopeia were searched to establish the availability of the plant monographs. Results. Of the 84 NDA-registered local products, only 18 were obtained from the market; 82 were indicated for respiratory tract disorders. Thirty-three plant materials were listed with Eucalyptus globulus Labill, being the commonest. Several in vitro and in vivo studies demonstrate efficacy, thus supporting the use of the selected plant species for empirical treatment as stated on the product label. While most plants were safe, some species such as Albizia coriaria Oliv. had dose-dependent toxicities that cannot be predicted in combinations. The WHO, African Pharmacopoeia, and West African Herbal Pharmacopoeia had only 16 plant monographs of the 33 plants of interest. Nevertheless, Aloe vera (L.) Burm.f., Azadirachta indica A.Juss., Zingiber officinale Roscoe, and Allium sativum L. monographs were published by all three pharmacopoeias. Conclusions. Preclinical evidence of safety and efficacy exists in the literature for most of the plants used to manufacture registered herbal products in Uganda. More specific bioassays and clinical trials are required for the products to provide conclusive evidence of safety and toxicity. Monographs are urgently needed for the Ugandan plants.

1 January 2018 in Journal of Pharmacy and Pharmacology Research
Verified
Journal Article
Open access
SNSandra Namunana
Sandra Namunana
SLStephen Lutoti
Stephen Lutoti
GNGrace Nyamaizi
Grace Nyamaizi
GAGerald Agaba
Gerald Agaba
IAIrene Apun
Irene Apun
PEPatrick Ogwang Engeu
Patrick Ogwang Engeu
Formulation, Development and Validation of a Wound Healing Herbal Ointment from Extracts of Bidens pilosa and Aloe barbadensis, Journal of Pharmacy and Pha

1 September 2020 in Scientific African
Verified
Journal Article
Open access
FOFrancis Omujal
Francis Omujal
KTKibira Irene Tenda
Kibira Irene Tenda
SLStephen Lutoti
Stephen Lutoti
IKIrene Kirabo
Irene Kirabo
SKSimon Dembe Kasango
Simon Dembe Kasango
KNKyeyune Grace Nambatya
Kyeyune Grace Nambatya

1 January 2018 in Archives of Microbiology & Immunology
Verified
Journal Article
Open access
SKSimon Dembe Kasango
Simon Dembe Kasango
SLStephen Lutoti
Stephen Lutoti
IWIzale Wewedru
Izale Wewedru
EAEmmanuel Aboce
Emmanuel Aboce
DADenish Calmax Angol
Denish Calmax Angol
Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamase Producers in Gram-negative Urine Isolates at MBN Clinical Laborator

15 September 2016 in Scientific Research and Essays
Verified
Journal Article
Open access
PDF file
FPFadhiru Kamba Pakoyo
Fadhiru Kamba Pakoyo
EMEdson Ireeta Munanura
Edson Ireeta Munanura
KBKaggwa Bruhan
Kaggwa Bruhan
LSLutoti Stephen
Lutoti Stephen
BHBush Aguma Herbert
Bush Aguma Herbert
OROdoi Adome Richard
Odoi Adome Richard
Tropical Africa has one of the world’s largest endowments in medicinal plant diversity. However, this potential has not been translated into pure drugs of proven efficacy and safety synonymous with modern pharmaceuticals. The basis for the slow translation of Tropical Africa’s medicinal plant wealth into value-added medicines acceptable in the doctor’s clinic is not clear. In this work, we sought to understand the patterns of research on African medicinal plants in general, and the capacity of sub-Saharan universities to conduct value-building research on plant-derived medicines in particular, using an extensive online search. A near-exponential growth in number of publications over the period 2000 to 2015 was found. However, most of the primary literature is on preliminary pharmacological assays and ethnobotany/ethnopharmacology. Only 6% of the publications are on advanced investigations such as isolation, structure elucidation and semi-synthetic optimization of natural compounds, structural studies of drug targets, ligand binding studies and cell biological assays, yet they are fundamental to progression of lead compounds into useful drugs. Assessment of the current biomolecular infrastructure in 25 sub-Saharan universities found severe shortage of essential equipment in many of them. Only 64, 68, 36 and 68% of the sampled universities have high performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), and nuclear magnetic resonance (NMR) equipment, respectively. East, Central and West Africa are particularly deficient in most of the key equipment, and some available are non-functional. The purchase cost of most biomolecular research equipment is between USD 30,000 and USD 500,000. Further analysis shows that the cost of establishing comprehensive biomolecular research infrastructure in at least one university per sub-Saharan nation is negligible relative to their gross domestic products (GDPs). Thus, even with the current economic resources, sub-Saharan African countries would upgrade biomolecular research capabilities in their leading universities without disrupting other economic priorities. Key words: Medicinal plants, biomolecular, Tropical Africa, nuclear magnetic resonance (NMR), liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), analog synthesis.